collection
Collections Big 4 Journals: Healthcare Lib...

Big 4 Journals: Healthcare Library of Northern Ireland

https://read.qxmd.com/read/37224199/the-current-and-future-state-of-ai-interpretation-of-medical-images
#1
REVIEW
Pranav Rajpurkar, Matthew P Lungren
New England Journal of Medicine, Volume 388, Issue 21, Page 1981-1990, May 2023.
May 25, 2023: New England Journal of Medicine
https://read.qxmd.com/read/37224198/upadacitinib-induction-and-maintenance-therapy-for-crohn-s-disease
#2
RANDOMIZED CONTROLLED TRIAL
Edward V Loftus, Julian Panés, Ana P Lacerda, Laurent Peyrin-Biroulet, Geert D'Haens, Remo Panaccione, Walter Reinisch, Edouard Louis, Minhu Chen, Hiroshi Nakase, Jakob Begun, Brigid S Boland, Charles Phillips, Mohamed-Eslam F Mohamed, Jianzhong Liu, Ziqian Geng, Tian Feng, Elena Dubcenco, Jean-Frederic Colombel
BACKGROUND: Upadacitinib, an oral selective Janus kinase (JAK) inhibitor, is under investigation for the treatment of Crohn's disease. METHODS: In two phase 3 induction trials (U-EXCEL and U-EXCEED), we randomly assigned patients with moderate-to-severe Crohn's disease to receive 45 mg of upadacitinib or placebo (2:1 ratio) once daily for 12 weeks. Patients who had a clinical response to upadacitinib induction therapy were randomly assigned in the U-ENDURE maintenance trial to receive 15 mg of upadacitinib, 30 mg of upadacitinib, or placebo (1:1:1 ratio) once daily for 52 weeks...
May 25, 2023: New England Journal of Medicine
https://read.qxmd.com/read/37224197/platelet-transfusion-before-cvc-placement-in-patients-with-thrombocytopenia
#3
RANDOMIZED CONTROLLED TRIAL
Floor L F van Baarle, Emma K van de Weerdt, Walter J F M van der Velden, Roelof A Ruiterkamp, Pieter R Tuinman, Paula F Ypma, Walter M van den Bergh, Astrid M P Demandt, Emile D Kerver, A J Gerard Jansen, Peter E Westerweel, Sesmu M Arbous, Rogier M Determann, Walther N K A van Mook, Mirelle Koeman, Anja B U Mäkelburg, Krijn P van Lienden, Jan M Binnekade, Bart J Biemond, Alexander P J Vlaar
BACKGROUND: Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence. The routine use of ultrasound guidance has decreased CVC-related bleeding complications. METHODS: In a multicenter, randomized, controlled, noninferiority trial, we randomly assigned patients with severe thrombocytopenia (platelet count, 10,000 to 50,000 per cubic millimeter) who were being treated on the hematology ward or in the intensive care unit to receive either one unit of prophylactic platelet transfusion or no platelet transfusion before ultrasound-guided CVC placement...
May 25, 2023: New England Journal of Medicine
https://read.qxmd.com/read/37224196/meningococcal-acwyx-conjugate-vaccine-in-2-to-29-year-olds-in-mali-and-gambia
#4
RANDOMIZED CONTROLLED TRIAL
Fadima C Haidara, Ama Umesi, Samba O Sow, Magnus Ochoge, Fatoumata Diallo, Abdulazeez Imam, Youssouf Traore, Lucy Affleck, Moussa F Doumbia, Bubacarr Daffeh, Mamoudou Kodio, Oghenebrume Wariri, Awa Traoré, Edrissa Jallow, Beate Kampmann, Dhananjay Kapse, Prasad S Kulkarni, Asha Mallya, Sunil Goel, Pankaj Sharma, Annamraju D Sarma, Nikhil Avalaskar, F Marc LaForce, Mark R Alderson, Abdi Naficy, Steve Lamola, Yuxiao Tang, Lionel Martellet, Nancy Hosken, Evangelos Simeonidis, Jo Anne Welsch, Milagritos D Tapia, Ed Clarke
BACKGROUND: An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a pentavalent vaccine targeting the A, C, W, Y, and X serogroups, have been limited. METHODS: We conducted a phase 3, noninferiority trial involving healthy 2-to-29-year-olds in Mali and Gambia. Participants were randomly assigned in a 2:1 ratio to receive a single intramuscular dose of NmCV-5 or the quadrivalent vaccine MenACWY-D...
May 25, 2023: New England Journal of Medicine
https://read.qxmd.com/read/36942789/hydrocortisone-in-severe-community-acquired-pneumonia
#5
RANDOMIZED CONTROLLED TRIAL
Pierre-François Dequin, Ferhat Meziani, Jean-Pierre Quenot, Toufik Kamel, Jean-Damien Ricard, Julio Badie, Jean Reignier, Nicholas Heming, Gaëtan Plantefève, Bertrand Souweine, Guillaume Voiriot, Gwenhaël Colin, Jean-Pierre Frat, Jean-Paul Mira, Nicolas Barbarot, Bruno François, Guillaume Louis, Sébastien Gibot, Christophe Guitton, Christophe Giacardi, Sami Hraiech, Sylvie Vimeux, Erwan L'Her, Henri Faure, Jean-Etienne Herbrecht, Camille Bouisse, Aurélie Joret, Nicolas Terzi, Arnaud Gacouin, Charlotte Quentin, Mercé Jourdain, Marie Leclerc, Carine Coffre, Hélène Bourgoin, Céline Lengellé, Caroline Caille-Fénérol, Bruno Giraudeau, Amélie Le Gouge
BACKGROUND: Whether the antiinflammatory and immunomodulatory effects of glucocorticoids may decrease mortality among patients with severe community-acquired pneumonia is unclear. METHODS: In this phase 3, multicenter, double-blind, randomized, controlled trial, we assigned adults who had been admitted to the intensive care unit (ICU) for severe community-acquired pneumonia to receive intravenous hydrocortisone (200 mg daily for either 4 or 7 days as determined by clinical improvement, followed by tapering for a total of 8 or 14 days) or to receive placebo...
May 25, 2023: New England Journal of Medicine
https://read.qxmd.com/read/37167988/evidence-based-antenatal-interventions-to-reduce-the-incidence-of-small-vulnerable-newborns-and-their-associated-poor-outcomes
#6
REVIEW
G Justus Hofmeyr, Robert E Black, Ewelina Rogozińska, Austin Heuer, Neff Walker, Per Ashorn, Ulla Ashorn, Nita Bhandari, Zulfiqar A Bhutta, Annariina Koivu, Somesh Kumar, Joy E Lawn, Stephen Munjanja, Pieta Näsänen-Gilmore, Doreen Ramogola-Masire, Marleen Temmerman
A package of care for all pregnant women within eight scheduled antenatal care contacts is recommended by WHO. Some interventions for reducing and managing the outcomes for small vulnerable newborns (SVNs) exist within the WHO package and need to be more fully implemented, but additional effective measures are needed. We summarise evidence-based antenatal and intrapartum interventions (up to and including clamping the umbilical cord) to prevent vulnerable births or improve outcomes, informed by systematic reviews...
May 20, 2023: Lancet
https://read.qxmd.com/read/37167990/biological-and-pathological-mechanisms-leading-to-the-birth-of-a-small-vulnerable-newborn
#7
REVIEW
Patricia J Hunter, Toluwalase Awoyemi, Adejumoke I Ayede, R Matthew Chico, Anna L David, Kathryn G Dewey, Christopher P Duggan, Michael Gravett, Andrew J Prendergast, Usha Ramakrishnan, Per Ashorn, Nigel Klein
The pathway to a thriving newborn begins before conception and continues in utero with a healthy placenta and the right balance of nutrients and growth factors that are timed and sequenced alongside hormonal suppression of labour until a mature infant is ready for birth. Optimal nutrition that includes adequate quantities of quality protein, energy, essential fats, and an extensive range of vitamins and minerals not only supports fetal growth but could also prevent preterm birth by supporting the immune system and alleviating oxidative stress...
May 20, 2023: Lancet
https://read.qxmd.com/read/37167989/small-babies-big-risks-global-estimates-of-prevalence-and-mortality-for-vulnerable-newborns-to-accelerate-change-and-improve-counting
#8
REVIEW
Joy E Lawn, Eric O Ohuma, Ellen Bradley, Lorena Suárez Idueta, Elizabeth Hazel, Yemisrach B Okwaraji, Daniel J Erchick, Judith Yargawa, Joanne Katz, Anne C C Lee, Mike Diaz, Mihretab Salasibew, Jennifer Requejo, Chika Hayashi, Ann-Beth Moller, Elaine Borghi, Robert E Black, Hannah Blencowe
Small newborns are vulnerable to mortality and lifelong loss of human capital. Measures of vulnerability previously focused on liveborn low-birthweight (LBW) babies, yet LBW reduction targets are off-track. There are two pathways to LBW, preterm birth and fetal growth restriction (FGR), with the FGR pathway resulting in the baby being small for gestational age (SGA). Data on LBW babies are available from 158 (81%) of 194 WHO member states and the occupied Palestinian territory, including east Jerusalem, with 113 (58%) having national administrative data, whereas data on preterm births are available from 103 (53%) of 195 countries and areas, with only 64 (33%) providing national administrative data...
May 20, 2023: Lancet
https://read.qxmd.com/read/37167991/small-vulnerable-newborns-big-potential-for-impact
#9
REVIEW
Per Ashorn, Ulla Ashorn, Yvonne Muthiani, Samira Aboubaker, Sufia Askari, Rajiv Bahl, Robert E Black, Nita Dalmiya, Christopher P Duggan, G Justus Hofmeyr, Stephen H Kennedy, Nigel Klein, Joy E Lawn, Jeremy Shiffman, Jonathon Simon, Marleen Temmerman
Despite major achievements in child survival, the burden of neonatal mortality has remained high and even increased in some countries since 1990. Currently, most neonatal deaths are attributable to being born preterm, small for gestational age (SGA), or with low birthweight (LBW). Besides neonatal mortality, these conditions are associated with stillbirth and multiple morbidities, with short-term and long-term adverse consequences for the newborn, their families, and society, resulting in a major loss of human capital...
May 20, 2023: Lancet
https://read.qxmd.com/read/37121242/effectiveness-of-handwashing-with-soap-for-preventing-acute-respiratory-infections-in-low-income-and-middle-income-countries-a-systematic-review-and-meta-analysis
#10
JOURNAL ARTICLE
Ian Ross, Sarah Bick, Philip Ayieko, Robert Dreibelbis, Jennyfer Wolf, Matthew C Freeman, Elizabeth Allen, Michael Brauer, Oliver Cumming
BACKGROUND: Acute respiratory infection (ARI) is a leading cause of morbidity and mortality globally, with 83% of ARI mortality occurring in low-income and middle-income countries (LMICs) before the COVID-19 pandemic. We aimed to estimate the effect of interventions promoting handwashing with soap on ARI in LMICs. METHODS: In our systematic review and meta-analysis, we searched MEDLINE, Embase, Web of Science, Scopus, Cochrane Library, Global Health, and Global Index Medicus for studies of handwashing with soap interventions in LMICs from inception to May 25, 2021...
May 20, 2023: Lancet
https://read.qxmd.com/read/37086744/respiratory-syncytial-virus-infection-during-infancy-and-asthma-during-childhood-in-the-usa-inspire-a-population-based-prospective-birth-cohort-study
#11
JOURNAL ARTICLE
Christian Rosas-Salazar, Tatiana Chirkova, Tebeb Gebretsadik, James D Chappell, R Stokes Peebles, William D Dupont, Samadhan J Jadhao, Peter J Gergen, Larry J Anderson, Tina V Hartert
BACKGROUND: Early-life severe respiratory syncytial virus (RSV) infection has been associated with the onset of childhood wheezing illnesses. However, the relationship between RSV infection during infancy and the development of childhood asthma is unclear. We aimed to assess the association between RSV infection during infancy and childhood asthma. METHODS: INSPIRE is a large, population-based, birth cohort of healthy infants with non-low birthweight born at term between June and December, 2012, or between June and December, 2013...
May 20, 2023: Lancet
https://read.qxmd.com/read/37068504/zolbetuximab-plus-mfolfox6-in-patients-with-cldn18-2-positive-her2-negative-untreated-locally-advanced-unresectable-or-metastatic-gastric-or-gastro-oesophageal-junction-adenocarcinoma-spotlight-a-multicentre-randomised-double-blind-phase-3-trial
#12
RANDOMIZED CONTROLLED TRIAL
Kohei Shitara, Florian Lordick, Yung-Jue Bang, Peter Enzinger, David Ilson, Manish A Shah, Eric Van Cutsem, Rui-Hua Xu, Giuseppe Aprile, Jianming Xu, Joseph Chao, Roberto Pazo-Cid, Yoon-Koo Kang, Jianning Yang, Diarmuid Moran, Pranob Bhattacharya, Ahsan Arozullah, Jung Wook Park, Mok Oh, Jaffer A Ajani
BACKGROUND: Zolbetuximab, a monoclonal antibody targeting claudin-18 isoform 2 (CLDN18.2), has shown efficacy in patients with CLDN18.2-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma. We report the results of the SPOTLIGHT trial, which investigated the efficacy and safety of first-line zolbetuximab plus mFOLFOX6 (modified folinic acid [or levofolinate], fluorouracil, and oxaliplatin regimen) versus placebo plus mFOLFOX6 in patients with CLDN18...
May 20, 2023: Lancet
https://read.qxmd.com/read/37219553/transcatheter-mitral-valve-repair-for-degenerative-mitral-regurgitation
#13
JOURNAL ARTICLE
Raj R Makkar, Joanna Chikwe, Tarun Chakravarty, Qiudong Chen, Patrick T O'Gara, Marc Gillinov, Michael J Mack, Andrew Vekstein, Dhairya Patel, Amanda Lee Stebbins, Annetine C Gelijns, Moody Makar, Deepak L Bhatt, Samir Kapadia, Sreekanth Vemulapalli, Martin B Leon
IMPORTANCE: There are limited data on the outcomes of transcatheter edge-to-edge mitral valve repair for degenerative mitral regurgitation (MR) in a real-world setting. OBJECTIVE: To evaluate the outcomes of transcatheter mitral valve repair for degenerative MR. DESIGN, SETTING, AND PARTICIPANTS: Cohort study of consecutive patients in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry who underwent nonemergent transcatheter mitral valve repair for degenerative MR in the US from 2014 through 2022...
May 23, 2023: JAMA
https://read.qxmd.com/read/37219552/coronary-artery-calcium-score-and-polygenic-risk-score-for-the-prediction-of-coronary-heart-disease-events
#14
MULTICENTER STUDY
Sadiya S Khan, Wendy S Post, Xiuqing Guo, Jingyi Tan, Fang Zhu, Daniel Bos, Bahar Sedaghati-Khayat, Jeroen van Rooij, Aaron Aday, Norrina B Allen, Maxime M Bos, André G Uitterlinden, Matthew J Budoff, Donald M Lloyd-Jones, Jonathan D Mosley, Jerome I Rotter, Philip Greenland, Maryam Kavousi
IMPORTANCE: Coronary artery calcium score and polygenic risk score have each separately been proposed as novel markers to identify risk of coronary heart disease (CHD), but no prior studies have directly compared these markers in the same cohorts. OBJECTIVE: To evaluate change in CHD risk prediction when a coronary artery calcium score, a polygenic risk score, or both are added to a traditional risk factor-based model. DESIGN, SETTING, AND PARTICIPANTS: Two observational population-based studies involving individuals aged 45 years through 79 years of European ancestry and free of clinical CHD at baseline: the Multi-Ethnic Study of Atherosclerosis (MESA) study involved 1991 participants at 6 US centers and the Rotterdam Study (RS) involved 1217 in Rotterdam, the Netherlands...
May 23, 2023: JAMA
https://read.qxmd.com/read/37120800/community-health-workers-in-early-childhood-well-child-care-for-medicaid-insured-children-a-randomized-clinical-trial
#15
RANDOMIZED CONTROLLED TRIAL
Tumaini R Coker, Kendra Liljenquist, Sarah J Lowry, Kevin Fiscella, Marcia R Weaver, Janette Ortiz, Rachel LaFontaine, Javier Silva, Taylor Salaguinto, Gina Johnson, Lisa Friesema, Lorena Porras-Javier, Laura J Sotelo Guerra, Peter G Szilagyi
IMPORTANCE: An intervention model (the Parent-focused Redesign for Encounters, Newborns to Toddlers; the PARENT intervention) for well-child care that integrates a community health worker into preventive care services may enhance early childhood well-child care. OBJECTIVE: To examine the effectiveness of the PARENT intervention vs usual care for parents with children younger than 2 years of age. DESIGN, SETTING, AND PARTICIPANTS: A cluster randomized clinical trial was conducted between March 2019 and July 2022...
May 23, 2023: JAMA
https://read.qxmd.com/read/37219554/reducing-opioid-use-for-chronic-pain-with-a-group-based-intervention-a-randomized-clinical-trial
#16
RANDOMIZED CONTROLLED TRIAL
Harbinder K Sandhu, Katie Booth, Andrea D Furlan, Jane Shaw, Dawn Carnes, Stephanie J C Taylor, Charles Abraham, Sharisse Alleyne, Shyam Balasubramanian, Lauren Betteley, Kirstie L Haywood, Cynthia P Iglesias-Urrutia, Sheeja Krishnan, Ranjit Lall, Andrea Manca, Dipesh Mistry, Sian Newton, Jennifer Noyes, Vivien Nichols, Emma Padfield, Anisur Rahman, Kate Seers, Nicole K Y Tang, Colin Tysall, Sam Eldabe, Martin Underwood
IMPORTANCE: Opioid use for chronic nonmalignant pain can be harmful. OBJECTIVE: To test whether a multicomponent, group-based, self-management intervention reduced opioid use and improved pain-related disability compared with usual care. DESIGN, SETTING, AND PARTICIPANTS: Multicentered, randomized clinical trial of 608 adults taking strong opioids (buprenorphine, dipipanone, morphine, diamorphine, fentanyl, hydromorphone, methadone, oxycodone, papaveretum, pentazocine, pethidine, tapentadol, and tramadol) to treat chronic nonmalignant pain...
May 23, 2023: JAMA
https://read.qxmd.com/read/37220916/the-promise-of-digital-health-technologies-for-integrated-care-for-maternal-and-child-health-and-non-communicable-diseases
#17
JOURNAL ARTICLE
Téa E Collins, Svetlana Akselrod, Aliina Altymysheva, Pham Thi Quynh Nga, Nick Banatvala, Daria Berlina
No abstract text is available yet for this article.
May 23, 2023: BMJ: British Medical Journal
https://read.qxmd.com/read/37220940/building-an-interdisciplinary-workforce-for-prevention-and-control-of-non-communicable-diseases-the-role-of-e-learning
#18
JOURNAL ARTICLE
Svetlana Akselrod, Téa E Collins, Connie Hoe, Julia Seyer, Kate Tulenko, Flaminia Ortenzi, Daria Berlina, Howard Sobel
Svetlana Akselrod and colleagues argue that interdisciplinary education for health workers, including through e-learning programmes, can help improve the quality of integrated care for non-communicable diseases
May 23, 2023: BMJ: British Medical Journal
https://read.qxmd.com/read/37220917/integrating-perinatal-mental-healthcare-into-maternal-and-perinatal-services-in-low-and-middle-income-countries
#19
JOURNAL ARTICLE
Gergana Manolova, Ahmed Waqas, Neerja Chowdhary, Tatiana Taylor Salisbury, Tarun Dua
Gergana Manolova and colleagues argue for a comprehensive approach to the challenge of treating perinatal mental health conditions in maternal, neonatal, and child health services
May 23, 2023: BMJ: British Medical Journal
https://read.qxmd.com/read/37220941/adverse-outcomes-of-sars-cov-2-infection-with-delta-and-omicron-variants-in-vaccinated-versus-unvaccinated-us-veterans-retrospective-cohort-study
#20
JOURNAL ARTICLE
Amy Sb Bohnert, Kyle Kumbier, Mazhgan Rowneki, Ashwin Gupta, Kristina Bajema, Denise M Hynes, Elizabeth Viglianti, Ann M O'Hare, Thomas Osborne, Edward J Boyko, Yinong Young-Xu, Theodore J Iwashyna, Matthew Maciejewski, Richard Schildhouse, Derek Dimcheff, George N Ioannou
OBJECTIVES: To determine the association between covid-19 vaccination types and doses with adverse outcomes of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection during the periods of delta (B.1.617.2) and omicron (B.1.1.529) variant predominance. DESIGN: Retrospective cohort. SETTING: US Veterans Affairs healthcare system. PARTICIPANTS: Adults (≥18 years) who are affiliated to Veterans Affairs with a first documented SARS-CoV-2 infection during the periods of delta (1 July-30 November 2021) or omicron (1 January-30 June 2022) variant predominance...
May 23, 2023: BMJ: British Medical Journal
label_collection
label_collection
19140
1
2
2023-05-26 08:56:57
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.